Ralph Niven Aerovate Therapeutics, Inc. (AVTE) insider trading activity

AVTE Quotes by TradingView

Ralph Niven is CHIEF SCIENTIFIC OFFICER of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 1,609 shares of AVTE, which is worth approximately $2,590. The most recent transaction as insider was on Feb 05, 2024, when has been sold 4,600 shares (Common Stock) at a price of $17.45 per share, resulting in proceeds of $80,270. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.61K
0% 3M change
0% 12M change
Total Value Held $2,590

RALPH NIVEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Open market or private sale
$80,270 $17.45 p/Share
4,600 Reduced 74.09%
1,609 Common Stock
Feb 05 2024
BUY
Exercise of conversion of derivative security
$8,924 $1.94 p/Share
4,600 Added 42.56%
6,209 Common Stock
Jan 05 2024
SELL
Open market or private sale
$87,952 $19.12 p/Share
4,600 Reduced 74.09%
1,609 Common Stock
Jan 05 2024
BUY
Exercise of conversion of derivative security
$8,924 $1.94 p/Share
4,600 Added 42.56%
6,209 Common Stock
Dec 05 2023
SELL
Open market or private sale
$74,980 $16.3 p/Share
4,600 Reduced 74.09%
1,609 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
$8,924 $1.94 p/Share
4,600 Added 42.56%
6,209 Common Stock
Nov 22 2023
SELL
Open market or private sale
$207,000 $15.0 p/Share
13,800 Reduced 89.56%
1,609 Common Stock
Nov 22 2023
BUY
Exercise of conversion of derivative security
$26,772 $1.94 p/Share
13,800 Added 47.25%
15,409 Common Stock
Jul 05 2023
SELL
Open market or private sale
$39,487 $17.55 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Jul 05 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Jun 05 2023
SELL
Open market or private sale
$36,585 $16.26 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Jun 05 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
May 05 2023
SELL
Open market or private sale
$47,722 $21.21 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
May 05 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Apr 05 2023
SELL
Open market or private sale
$41,647 $18.51 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Mar 06 2023
SELL
Open market or private sale
$54,742 $24.33 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Mar 06 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Feb 06 2023
SELL
Open market or private sale
$54,607 $24.27 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Feb 06 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Jan 05 2023
SELL
Open market or private sale
$59,400 $26.4 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Dec 05 2022
SELL
Open market or private sale
$39,105 $17.38 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$4,365 $1.94 p/Share
2,250 Added 36.83%
3,859 Common Stock
Nov 07 2022
SELL
Open market or private sale
$42,322 $18.81 p/Share
2,250 Reduced 58.31%
1,609 Common Stock
RN

Ralph Niven

CHIEF SCIENTIFIC OFFICER
Waltham,, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTE